These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37469401)

  • 1. Case Report: A case of hepatocellular carcinoma with aberrant right hepatic artery treated with transarterial chemoembolization and infusion chemotherapy separately to bilobar lesion combining with systemic therapies and sequential hepatectomy.
    Wei YG; Su H; Lv ZL; Liao XW; Zeng ZM; Jia YX; Huang HS; Shen XQ; Zhu GZ; Han CY; Ye XP; Peng T
    Front Oncol; 2023; 13():1165538. PubMed ID: 37469401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary approach for multifocal, bilobar hepatocellular carcinoma: A case report and literature review.
    Labadie KP; Schaub SK; Khorsand D; Johnson G; Apisarnthanarax S; Park JO
    World J Hepatol; 2019 Jan; 11(1):119-126. PubMed ID: 30705724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: hepatic arterial infusion chemotherapy combined with sintilimab and lenvatinib for conversion therapy of colorectal cancer liver metastases.
    Peng K; Li Y; Su H; Lan C; Huang Z; Wei Y; Liao X; Peng M; Peng T; Zhu G
    Front Immunol; 2023; 14():1325445. PubMed ID: 38173715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
    He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
    Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Artery Infusion Chemotherapy Sequential Hepatic Artery Embolization Combined with Operation in the Treatment of Recurrent Massive Hepatocellular Carcinoma Achieved Pathological Complete Response: A Case Report.
    Chen J; Liao X; Wu Y; Ou S; Qin W; Yang C; Tan Y; Lao Q; Peng M; Peng T; Ye X
    Pharmgenomics Pers Med; 2023; 16():949-958. PubMed ID: 37933333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic resection for bilobar hepatocellular carcinoma: is it justified?
    Liu CL; Fan ST; Lo CM; Ng IO; Poon RT; Wong J
    Arch Surg; 2003 Jan; 138(1):100-4. PubMed ID: 12511161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma.
    Kim HY; Kim JD; Bae SH; Park JY; Han KH; Woo HY; Choi JY; Yoon SK; Jang BK; Hwang JS; Kim SG; Kim YS; Seo YS; Yim HJ; Um SH;
    Korean J Hepatol; 2010 Dec; 16(4):355-61. PubMed ID: 21415578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of bilobar multiple hepatocellular carcinoma in which complete remission was achieved by preoperative percutaneous isolated hepatic perfusion and subsequent hepatectomy].
    Urade T; Tanaka M; Fukumoto T; Kido M; Tsuchida S; Takahashi M; Takebe A; Kuramitsu K; Awazu M; Chuma M; Fukushima K; So S; Tai K; Fujimoto M; Toyama H; Shinzeki M; Matsumoto I; Ajiki T; Ku Y
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1825-7. PubMed ID: 23267899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of literature.
    Chu JH; Huang LY; Wang YR; Li J; Han SL; Xi H; Gao WX; Cui YY; Qian MP
    World J Gastrointest Oncol; 2024 Apr; 16(4):1647-1659. PubMed ID: 38660668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
    Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
    Trials; 2012 Aug; 13():144. PubMed ID: 22913492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of transarterial chemoembolization/hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitor is effective against hepatocellular carcinoma with portal vein tumor thrombus: A systematic review.
    Yuanren G; Yin L; Liu R; Cui Y
    Front Oncol; 2023; 13():1054072. PubMed ID: 36969065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinoma.
    Chen K; Luo CP; Ge DX; Wang KL; Luo Q; Li YZ; You XM; Xiang BD; Li LQ; Ma L; Zhong JH
    Front Oncol; 2022; 12():946693. PubMed ID: 36276151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy Combined a Tyrosine Kinase Inhibitor for Treatment of Large Hepatocellular Carcinoma.
    Chen B; Dai H; Yang J; Zhang G; Wen C; Xiang X; Lin R; Huang Y
    Curr Cancer Drug Targets; 2023; 23(7):564-571. PubMed ID: 36790005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curative surgery for multiple hepatocellular carcinomas after lenvatinib plus transarterial chemoembolization: a case report.
    Shiraishi J; Itoh S; Tomino T; Yoshiya S; Nagao Y; Morita K; Kayashima H; Harada N; Ichiki Y; Yoshizumi T
    J Surg Case Rep; 2023 Aug; 2023(8):rjad485. PubMed ID: 37645700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
    Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic arterial infusion chemotherapy versus transarterial chemoembolization for unresectable hepatocellular carcinoma: A systematic review with meta-analysis.
    Si T; Huang Z; Khorsandi SE; Ma Y; Heaton N
    Front Bioeng Biotechnol; 2022; 10():1010824. PubMed ID: 36237208
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic Survival Factors of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
    Rohan T; Uher M; Matkulčík P; Zavadil J; Ostřížková L; Kiss I; Andrašina T; Válek V
    Klin Onkol; 2020; 33(3):214-219. PubMed ID: 32683878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of preoperative percutaneous isolated hepatic perfusion and hepatectomy in multidisciplinary treatment].
    Yoshida T; Kido M; Fukumoto T; Komatsu S; Takahashi M; Takebe A; Tanaka M; Kuramitsu K; Kinoshita H; Ajiki T; Matsumoto I; Shinzeki M; Okazaki T; Asari S; Ku Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1822-4. PubMed ID: 24393934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic arterial infusion chemotherapy with implantable arterial access port for advanced-stage hepatocellular carcinoma: a case report.
    Jiang X; Aljbri A; Liu J; Shang L; Tian Y; Shao H
    Front Oncol; 2024; 14():1401882. PubMed ID: 38817896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of tumor stage and initial treatment modality in patients with primary hepatocellular carcinoma.
    Xiang X; Zhong JH; Wang YY; You XM; Ma L; Xiang BD; Li LQ
    Clin Transl Oncol; 2017 Jul; 19(7):891-897. PubMed ID: 28160206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.